Метаболический синдром у больных системной красной волчанкой
https://doi.org/10.14412/1995-4484-2008-530
Аннотация
Ключевые слова
Об авторах
T Y PopkovaД. С. Новикова
E. V. Gerasimova
E N Alexandrova
А. А. Новиков
E S Maeh
S. S. Alekberova
Евгений Львович Насонов
Список литературы
1. <div><p>Насонова В. А. Системная красная волчанка. М., Медицина, 1972.</p><p>Cervera R. Khamashta М. A., Font J. etal. Morbidity and mortality in systemic lupus erythematosus during a Ю-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore), 2003, 82, 299-308.</p><p>Pistiner М., Wallance D. J., Nessim S. et al. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin. Arthr. Rheum., 1991, 21, 55-64.</p><p>Bruce I. N., Urowitz М. B., Ibanez D., Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus. Arthr. Rheum., 2003, 48, 3159-67.</p><p>Manzj S., Selzer F., Kuller L. H. et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthr. Rheum., 1999, 42, 51-60.</p><p>Esdaile J. М., Abrahamowicz М., Grozicky T. et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthr. Rheum., 2001, 44. 223137.</p><p>Насонов E. Л. Проблема атеротромбоза в ревматологии. Вестник РАМН, 2003, 7, 6-10.</p><p>Chung С. P., Avalos /., OeserA. et al. High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann. Rheum. Dis. 2007, 66, 208-214</p><p>Magadmi M, Ahmad Y., Turkie W. et al. Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus. J. Rheumatol., 2006, 33, 50-56</p><p>Мамедов М. H., Перова H. В., Косматова О. В. и др. Перспективы коррекции проявлении метаболического синдрома, влияние сочетанной гипотензивной и гиполипидемической терапии на уровень суммарного коронарного риска и тканевую инсу- линорезистентность. Кардиология, 2003, 43, 3, 13-19</p><p>Wilson P. W, Kannel W. В., Silbershatz Н. et al. Clustering of metabolic factors and coronary heart disease. Arch. Intern. Med., 1999, 159, 1104-1109</p><p>Насонов E. Л. Иммунологические маркеры атеросклероза. Тер. архив., 2002, 5, 80-85</p><p>Szmitko P. Е., Wang С. Н., Weisel R. D. et al. New markers of inflammation and endothelial cell activation, part I. Circulation, 2003, 108, 1917-1923</p><p>Szmitko P. E., Wang С. H., Weisel R. D. et al. New markers of inflammation and endothelial cell activation, pan II. Circulation, 2003, 108, 2041-2048</p><p>Насонов E. Л. Иммунологические маркеры атеросклероза. В кн. Антифосфолипидный синдром. М., Из-во «Литтера», 2004, 278-298</p><p>Visser М., Вой ter L. М., McQuillan G. М. et al. Elevated C-reactive protein levels in overweisht and obese adults. J. Am. Med. Assoc., 1999, 282, 21312135</p><p>Tsukui S., Kanda Т., Nara M. et al. Moderate- intensity regular exercise decreases tumor necrosis factor-a and HbAk levels in healthy women. Int. J. Obesity, 2000, 24, 1207-1211</p><p>Zahorska-Markiewicz B., Janowska J., Olszanecka- Glinianowicz M. Serum concentrations ofTNF-a and soluble TNF-a receptors in obesity. Int. J. Obesity. 2000, 24, 1392-1395</p><p>Frochlich М., Imhof A., Berg G. et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care, 2000, 23, 1835-1839</p><p>Festa A., DAgostino R. lr., Howard G. et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation, 2000, 102, 42-47</p><p>Blake G. J., Ridker P. M. Novel clinical markers of vascular wall inflammation. Circulation Res., 2001, 89, 763-771</p><p>Fernandez-Real J. М., Vayreda М., Richart C. et al. Circulating interleukin-6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J. Clin. Endocrinol. Metab., 2001, 86, 11541159</p><p>Tan E. N., Cohen A. S., Masi A. N. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr. Rheum., 1982,25, 1271-77.</p><p>Vitali C., Bencivelli W, Isenberg D. A. et al. Disease activity in SLE: report of the Consensus Study Group of the European Workshop for Rheumatology Research. И Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin. Exp. Rheumatol., 1992,10. 541-47.</p><p>Gladman D., Glizler E., Goldsmith C. et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthr. Rheum., 1996, 39, 363-369.</p><p>Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Summary’ of the second report of the national cholesterol education program (NCEP) expert panel detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). JAMA, 1993, 269, 3015-3023.</p><p>National Cholesterol Education Program. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 2001, 285, 2486-2497</p><p>Диагностика и лечение стабильной стенокардии. Российские рекомендации. В НО К, М., 2004, 7-11</p><p>Howard G., Sharreit A. R., Heiss G. el at. Carotid artery intima-media thickness distribution in general populations as evaluated by В-mode ultrasound. ARIC Investigators. Stmke. 1993, 24. 1297-304</p><p>lannuzzi A., Michele M. D., Panico S. et al. Radical- Trapping Activity, Blood Pressure, and Carotid Enlargement in women. Hypertension., 2003, 41, 289-296</p><p>ArtissJ. D., Zak B. Measurement of cholesterol concentration. In: Rifai N. WarmicG. R., Dominiczak M. И., eds. Handbook of lipoprotein testing. Washington : AACC Press, 1997, 99-114</p><p>Friedwald W. Т., Levy R. J., Fredrickson D. S. Estimation of the calculation of LDL cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem., 1972, 18, 499-502</p><p>Baikalt B., Charles M. A., Drivsholm T. etal. Freguence of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabet. Metab., 2002, 28, 364-367</p><p>Chung С. P., OeserA., Solus J. et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atliemsclerosis, 2007, 196, 765- 769</p><p>Karvounaris S. A., Sidiropoulos P. I., Papadakis J. A. et al. Metabolic syndrome is common among middle- to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann. Rheum. Dis., 2007, 66, 28-33</p><p>Roman M. J., Shanker B. A., Davis A. etal. Prevalence and correlates of accelerated atherosclerosis in Systemic lupus erythematosus. New Engl. J. Med., 2003, 349, 2399-2406.</p><p>Rahman P., Urowitz М. B. Gladman D. D. et at. Contribution of traditional risk factor to coronary artery disease in patients with systemic lupus erythematosus. J. Rheumatol., 1999, 26, 363-368</p><p>Esdale J. М., Abrahamowicz М., Grodzicky T. et al. Traditional Framingham risk factor fail to fully account for accelerated atherosclemsis in systemic lupus erythematosus. Arthr. Rheum., 2001, 44, 23312337</p><p>Borba E. F., Bonfa E. Dyslipoproteinemias in SLE: influence of disease activity and anticardiolipin antibodies. Lupus, 1997, 6, 533-9.</p><p>Kirwan J. P., Krishnan R. K., Weaver J. A. et al. Human aging is associated with altered TNF-a. production during hyperglycemia and hyperinsulinemia. Am. J. Physiol., 2001, 281, El 137-El 143</p><p>Lin Y., Rajala M. W, Berger J. P. etal. Hyperglycemia- induced production of acute phase reactants in adipose tissue. J. Biol. Chem., 2001, 276, 42077-42083</p><p>Chae C. U., Lee R. Т., Rifai N. et al. Blood pressure and inflammation in apparently healthy men. Hypertension, 2001, 38, 399-403</p><p>Панафидина Т. А., Попкова Т. В., Алекберова3. С. и соавт. Значение факторов риска и С-реактивного белка в развитии атеросклероза у женщин с системной красной волчанкой. Клин, мед., 2006, 10, 49-54</p><p>Tso Т. К., Huang W-N. Elevated soluble intercellular adhesion molecule-1 levels in patients with systemic lupus erythematosus: relation to insulin resistance. J. Rheumatol., 2007, 34, 726-730</p><p>Dessein P., Jojfe В. I., Stanwix A. E. et al. Clucocorticoids and insulin sensitivity in rheumatoid arthritis. J. Rheumatol., 2004, 31, 867-874</p><p>Boers М., Nurmohamed М. Т., Doelman CJA. et al. Influence glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann. Rheum. Dis., 2003, 62, 842-845</p></div><br />
Рецензия
Для цитирования:
Popkova T.Y., Новикова Д.С., Gerasimova E.V., Alexandrova E.N., Новиков А.А., Maeh E.S., Alekberova S.S., Насонов Е.Л. Метаболический синдром у больных системной красной волчанкой. Научно-практическая ревматология. 2008;46(4):14-20. https://doi.org/10.14412/1995-4484-2008-530
For citation:
Popkova T.Y., Novikova D.S., Gerasimova E.V., Alexandrova E.N., Novikov A.A., Maeh E.S., Alekberova S.S., Nasonov E.L. Metabolic syndrome in patients with systemic lupus erythematosus. Rheumatology Science and Practice. 2008;46(4):14-20. (In Russ.) https://doi.org/10.14412/1995-4484-2008-530